Morningstar

BlackRock Health Sciences Opportunities Portfolio Service Shares SHISX

Morningstar Medalist Rating
Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 63.87  /  −0.44 %
  • Total Assets 6.3B
  • Adj. Expense Ratio
    1.150%
  • Expense Ratio 1.150%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Value
  • Min. Initial Investment 5,000
  • Status Open
  • TTM Yield 0.23%
  • Turnover 43%

USD | NAV as of Aug 15, 2026 | 1-Day Return as of Aug 15, 2026, 12:54 AM GMT+0

Morningstar’s Analysis SHISX

Will SHISX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable SHISX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the SHISX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of SHISX’s parent organization’s priorities and whether they’re in line with investors’ interests.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Svc holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

by Morningstar Automated Analysis
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHISX

More SHISX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 53.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.68 788M
Healthcare

Johnson & Johnson

7.87 489M
Healthcare

UnitedHealth Group Inc

6.34 394M
Healthcare

Merck & Co Inc

5.26 327M
Healthcare

AbbVie Inc

5.11 317M
Healthcare

Gilead Sciences Inc

3.74 233M
Healthcare

Amgen Inc

3.44 214M
Healthcare

Thermo Fisher Scientific Inc

3.18 197M
Healthcare

Vertex Pharmaceuticals Inc

2.89 180M
Healthcare

Edwards Lifesciences Corp

2.49 155M
Healthcare

Sponsor Center